Imiquimod a new adjuvant for telomerase peptide vaccine: A phase I trial in patients with inoperable pancreatic cancer.

被引：0
|
作者：
Bernhardt, SL
Buanes, TA
Moller, M
Eriksen, JA
Geudernack, G
机构：
[1] Univ Oslo, Ullevaal Hosp, N-0407 Oslo, Norway
[2] Gemvax, Porsgrunn, Norway
[3] Norwegian Radium Hosp, Oslo, Norway
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：867S / 867S
页数：1
相关论文
共 50 条
  • [41] Phase II adjuvant peptide vaccine for postoperative esophageal cancer patients with pathologically positive nodes
    Yasuda, Takushi
    Nishiki, Kohei
    Hiraki, Yoko
    Kato, Hiroaki
    Shiraishi, Osamu
    Yasuda, Atsushi
    Shinkai, Masayuki
    Kimura, Yutaka
    Sukegawa, Yasushi
    Chiba, Yasutaka
    Imano, Motohiro
    Takeda, Kazuyoshi
    Satou, Takao
    Shiozaki, Hitoshi
    Nakamura, Yusuke
    CANCER SCIENCE, 2021, 112 : 1021 - 1021
  • [42] Phase I Clinical Trial Using Peptide Vaccine for Human Vascular Endothelial Growth Factor Receptor 2 in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer
    Miyazawa, M.
    Tani, M.
    Kawai, M.
    Hirono, S.
    Okada, K.
    Shimizu, A.
    Kitahata, Y.
    Yamaue, H.
    PANCREAS, 2014, 43 (08) : 1392 - 1392
  • [43] Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer
    Miyazawa, Motoki
    Ohsawa, Ryuji
    Tsunoda, Takuya
    Hirono, Seiko
    Kawai, Manabu
    Tani, Masaji
    Nakamura, Yusuke
    Yamaue, Hiroki
    CANCER SCIENCE, 2010, 101 (02): : 433 - 439
  • [44] Phase II trial of imatinib mesylate in patients with metastatic. unresectable pancreatic cancer.
    Gharibo, MM
    Juvidian, P
    Patrick-Miller, L
    Zheng, L
    Craig, J
    Guensch, L
    Wojtaszek, C
    Poplin, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 353S - 353S
  • [45] Alliance A021806: A phase III trial evaluating perioperative versus adjuvant therapy for resectable pancreatic cancer.
    Chawla, Akhil
    Shi, Qian
    Ko, Andrew H.
    Beg, Shaalan
    Varghese, Anna M.
    Behrman, Stephen W.
    Bloomston, Mark
    Ahmed, Firas Salem
    Frankel, Wendy L.
    Dixon, Jesse G.
    Carrero, Xiomara W.
    Shergill, Ardaman
    Crawley, Jamie
    Akin, Oguz
    Renouf, Daniel John
    Zogopoulos, George
    Hubbard, Joleen M.
    Meyerhardt, Jeffrey A.
    O'Reilly, Eileen Mary
    Ferrone, Cristina R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Phase I clinical trial of hybrid cell vaccination in patients with gastrointestinal cancer.
    Iinuma, H.
    Okinaga, K.
    Iwasaki, K.
    Koide, T.
    Inaba, T.
    Fukushima, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 119S - 119S
  • [47] Phase I trial of oral topotecan with intravenous carboplatin in patients with advanced cancer.
    Ackler, LR
    Desai, A
    Leighton, JC
    Tester, WJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 240S - 240S
  • [48] Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer
    Miyazaki, Akihiro
    Kobayashi, Junichi
    Torigoe, Toshihiko
    Hirohashi, Yoshihiko
    Yamamoto, Takashi
    Yamaguchi, Akira
    Asanuma, Hiroko
    Takahashi, Akari
    Michifuri, Yoshitaka
    Nakamori, Kenji
    Nagai, Itaru
    Sato, Noriyuki
    Hiratsuka, Hiroyoshi
    CANCER SCIENCE, 2011, 102 (02) : 324 - 329
  • [49] Phase I trial of a melanoma vaccine with gp100280-288 peptide and tetanus helper peptide in adjuvant:: Immunologic and clinical outcomes
    Slingluff, CL
    Yamshchikov, G
    Neese, P
    Galavotti, H
    Eastham, S
    Engelhard, VH
    Kittlesen, D
    Deacon, D
    Hibbitts, S
    Grosh, WW
    Petroni, G
    Cohen, R
    Wiernasz, C
    Patterson, JW
    Conway, BP
    Ross, WG
    CLINICAL CANCER RESEARCH, 2001, 7 (10) : 3012 - 3024
  • [50] A phase II trial of gemcitabine and celecoxib for metastatic pancreatic cancer.
    Xiong, HQ
    Hess, KR
    Kayaleh, OR
    Goodwin, JW
    Banerjee, T
    Sinclair, SS
    Fisch, MJ
    Wolff, RA
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 351S - 351S
12345